COMMUNIQUÉS West-GlobeNewswire

Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update

07/11/2017 - 22:05

Net cash used in operating and investing activities was $18.3 million in the third quarter and $94.8 million for the first nine months of 2017; quarter-end cash and restricted cash position of $460.1 million, provides [...]

TRACON Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

07/11/2017 - 22:05

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Bellicum Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

HOUSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update

07/11/2017 - 22:05

Affirms plans to release Acuitas® AMR Gene Panel in the first quarter of 2018 Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) [...]

Kura Oncology Reports Third Quarter 2017 Financial Results and Provides Corporate Update

07/11/2017 - 22:05

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (Nasdaq: KURA ) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported third quarter [...]

AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017

07/11/2017 - 22:05

GAINESVILLE, Fla., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene [...]

Editas Medicine Announces Third Quarter 2017 Results and Update

07/11/2017 - 22:03

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today reported financial results for the third quarter ended September 30, 2017, and provided [...]

MannKind Corporation Reports 2017 Third Quarter Financial Results

07/11/2017 - 22:01

WESTLAKE VILLAGE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD ) today reported financial results for the third quarter and the nine months ended September 30, 2017. Third quarter [...]

Pernix Therapeutics Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:01

MORRISTOWN, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today financial results for the third [...]

Sientra Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:01

Completed FDA Facility Inspection Completed Acquisition of Miramar Labs and Making Significant Progress with Integration SANTA BARBARA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” [...]

Zogenix Provides Corporate Update and Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:01

During the third quarter, the Company announced positive top-line results from its Phase 3 Study 1 of ZX008 in patients with Dravet syndrome Study 1 met primary endpoint of reduction in frequency of convulsive seizures [...]

ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to Trial

07/11/2017 - 19:00

NEW HAVEN, Conn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- The Wings for Life foundation has made a significant commitment to ReNetX Bio, a New-Haven, Conn. based biotech startup that is advancing a cutting-edge therapy for [...]

Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients

07/11/2017 - 18:22

BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biodesix ® chief technology officer, Dr. Heinrich Roder, will give an oral presentation discussing a proprietary test development methodology that uses machine learning [...]

The Ensign Group Acquires Home Health and Hospice Operations in Oklahoma City, Oklahoma

07/11/2017 - 18:15

MISSION VIEJO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care, [...]

Konica Minolta Healthcare Awarded Healthcare IT Agreement for Exa with Premier

07/11/2017 - 17:54

WAYNE, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. has been awarded a group purchasing agreement for healthcare information technology (IT) with Premier. Effective January 1, 2018, [...]

Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological Association New York Section Annual Meeting in Havana

07/11/2017 - 17:15

HASBROUCK HEIGHTS, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report on the two data presentations which were held on Fexapotide Triflutate studies at the [...]

Canada Diagnostic Centres Contracts with eRAD

07/11/2017 - 16:42

GREENVILLE, S.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- eRAD announced today that Canada Diagnostic Centres (CDC), a 17-site imaging provider in Alberta, Canada, will implement an array of eRAD software solutions, including [...]

VBL Therapeutics to Report Third Quarter 2017 Results on November 14

07/11/2017 - 16:29

TEL AVIV, Israel, Nov. 07, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

CORRECTING and REPLACING – Elite Pharmaceuticals, Inc.

07/11/2017 - 16:27

NORTHVALE, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- In a release issued earlier today by Elite Pharmaceuticals, Inc. (OTCQB:ELTP), please note in the headline the conference call date should be "November 10" rather than [...]